Galectin-1-driven Upregulation of SDF-1 in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metastasis

Dong Qian,Zipeng Lu,Qingcheng Xu,Pengfei Wu,Lei Tian,Liangtao Zhao,Baobao Cai,Jie Yin,Yang Wu,Kevin F. Staveley-O'Carroll,Kuirong Jiang,Yi Miao,Guangfu Li
DOI: https://doi.org/10.1016/j.canlet.2017.03.024
IF: 9.756
2017-01-01
Cancer Letters
Abstract:Galectin-1, mainly expressed in activated pancreatic stellate cells (PSCs), is involved in many important cancer-related processes. However, very little is known how Galectin-1 modulates PSCs and subsequently impacts pancreatic cancer cells (PCCs). Our chemokine antibody array and in vitro studies demonstrates that Galectin-1 induces secretion of stromal cell-derived factor-1(SDF-1) in PSCs by activating NF-κB signaling. The secreted SDF-1 increases migration and invasion of PCCs. Knockdown of Galectin-1 and inhibitor-mediated blockade of SDF-1 as well as its ligand CXCR4 and NF-κB verifies the findings. In vivo experiment by knockdown of Galectin-1 in PSCs further demonstrates the conclusion. Collectively, the present studies demonstrate that Galectin-1-driven production of SDF-1 in PSCs through activation of NF-κB promotes metastasis in PDAC, offering a potential target in the treatment of pancreatic cancer.
What problem does this paper attempt to address?